Oslo, Norway

Arne Klungland

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.2

ph-index = 2

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2017-2023

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Arne Klungland: A Pioneer in Innovations and Gene Editing

Introduction:

Arne Klungland, a visionary inventor based in Oslo, NO, is renowned for his groundbreaking contributions to the field of gene editing. With a total of 5 patents to his name, Arne Klungland has made significant strides in the realm of genome perturbation and gene-editing technologies.

Latest Patents:

Arne Klungland's latest patents encompass cutting-edge advancements in gene editing and chromatin immunoprecipitation (ChIP-seq) assays. His work involves the development of systems, methods, and compositions that enable precise control of gene expression through sequence targeting, utilizing vector systems like recombinases and CRISPR components.

Career Highlights:

Arne Klungland's career is adorned with remarkable achievements, with a focus on pushing the boundaries of innovation in molecular biology and genetic engineering. His patents stand as a testament to his dedication to creating transformative solutions in the biotechnology landscape.

Collaborations:

Throughout his career, Arne Klungland has collaborated with esteemed professionals in the field, including Adam Brian Robertson and John Arne Dahl. These collaborations have led to the exchange of ideas, expertise, and knowledge, contributing to the success of his innovative projects.

Conclusion:

In conclusion, Arne Klungland emerges as a beacon of innovation and creativity, with a profound impact on the field of gene editing. His relentless pursuit of excellence, coupled with a passion for driving meaningful change through his inventions, cements his legacy as a pioneering figure in the realm of molecular biology and biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…